Study of the Specific Seroprevalence of SARS-CoV-2 in a Sample of Patients and Salaried Staff From a French Anti-cancer Center at the End of the Containment Period of the SARS-CoV-2 Pandemic
Clinical trial NCT04517097 · COMPLETED
Trial details
- NCT number
- NCT04517097
- Sponsor
- Centre Georges Francois Leclerc
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-05-12
- Primary completion
- 2020-06-30
- Enrollment
- 1680
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.